HUE040080T2 - Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates - Google Patents

Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates

Info

Publication number
HUE040080T2
HUE040080T2 HUE13714546A HUE13714546A HUE040080T2 HU E040080 T2 HUE040080 T2 HU E040080T2 HU E13714546 A HUE13714546 A HU E13714546A HU E13714546 A HUE13714546 A HU E13714546A HU E040080 T2 HUE040080 T2 HU E040080T2
Authority
HU
Hungary
Prior art keywords
cytostatica
cancers
reduction
treatment
combination
Prior art date
Application number
HUE13714546A
Other languages
Hungarian (hu)
Inventor
Martin Westphal
Silke Baasner
Original Assignee
Fresenius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland Gmbh filed Critical Fresenius Kabi Deutschland Gmbh
Publication of HUE040080T2 publication Critical patent/HUE040080T2/en

Links

HUE13714546A 2012-01-30 2013-01-30 Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates HUE040080T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261592017P 2012-01-30 2012-01-30
EP12153068 2012-01-30

Publications (1)

Publication Number Publication Date
HUE040080T2 true HUE040080T2 (en) 2019-02-28

Family

ID=65474822

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE13714546A HUE040080T2 (en) 2012-01-30 2013-01-30 Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates
HUE13701646A HUE041356T2 (en) 2012-01-30 2013-01-30 Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE13701646A HUE041356T2 (en) 2012-01-30 2013-01-30 Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates

Country Status (4)

Country Link
CY (2) CY1121443T1 (en)
HR (1) HRP20181814T1 (en)
HU (2) HUE040080T2 (en)
PT (2) PT2809329T (en)

Also Published As

Publication number Publication date
PT2809329T (en) 2018-11-16
PT2809327T (en) 2018-11-16
HUE041356T2 (en) 2019-05-28
CY1121445T1 (en) 2020-05-29
HRP20181814T1 (en) 2019-03-22
CY1121443T1 (en) 2020-05-29

Similar Documents

Publication Publication Date Title
IL237558A0 (en) Methods for the treatment of locally advanced breast cancer
IL238942A0 (en) Pyrimidine-2,4-diamine derivatives for treatment of cancer
GB2495841B (en) Phytocannabinoids for use in the treatment of breast cancer
HK1206338A1 (en) Pyrimidine compounds for the treatment of cancer
IL239007B (en) Eribulin for use in the treatment of breast cancer
HRP20180670T1 (en) Novel process for making compounds for use in the treatment of cancer
PT3400943T (en) Compounds for use in the treatment of erbb2+ brain cancer
EP2925752A4 (en) Pyrimidine compounds for the treatment of cancer
HRP20181754T1 (en) Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates
EP3733184C0 (en) Pyrimidine compounds for use in the treatment of cancer
PT2872176T (en) Carboranylporphyrins for use in the treatment of cancer
PL2855475T3 (en) Alpha-carbolines for the treatment of cancer
HRP20181814T1 (en) Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates
GB2507765B8 (en) Substituted pyridine derivatives useful in the treatment of cancer
PT2925744T (en) Pyrimidine-2,4-diamine derivatives for treatment of cancer